Do H. Kim

1.3k total citations
45 papers, 758 citations indexed

About

Do H. Kim is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Do H. Kim has authored 45 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Surgery and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Do H. Kim's work include Lymphoma Diagnosis and Treatment (11 papers), Aluminum Alloys Composites Properties (4 papers) and Viral gastroenteritis research and epidemiology (4 papers). Do H. Kim is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Aluminum Alloys Composites Properties (4 papers) and Viral gastroenteritis research and epidemiology (4 papers). Do H. Kim collaborates with scholars based in United States, South Korea and Canada. Do H. Kim's co-authors include Larry Zeitlin, Kevin J. Whaley, Ognian Bohorov, Michael Pauly, W.T. Kim, Gene G. Olinger, Ernie Hiatt, Josh Morton, Ashley E. Piper and Joshua C. Johnson and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Do H. Kim

42 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Do H. Kim United States 16 270 135 89 86 83 45 758
Chiara Giudice Italy 22 158 0.6× 92 0.7× 206 2.3× 26 0.3× 183 2.2× 103 1.5k
Philip Hartjen Germany 14 106 0.4× 142 1.1× 118 1.3× 198 2.3× 103 1.2× 41 1.2k
Eric Verbeken Belgium 16 219 0.8× 192 1.4× 324 3.6× 81 0.9× 78 0.9× 52 1.1k
Felipe Tapia Germany 9 62 0.2× 52 0.4× 126 1.4× 129 1.5× 148 1.8× 12 592
Tobias May Germany 19 54 0.2× 138 1.0× 161 1.8× 117 1.4× 465 5.6× 43 1.1k
Guan Liu China 18 335 1.2× 313 2.3× 160 1.8× 68 0.8× 236 2.8× 62 1.7k
Shaobing Li China 19 175 0.6× 474 3.5× 175 2.0× 67 0.8× 118 1.4× 73 1.2k
Corey J. Bishop United States 17 90 0.3× 55 0.4× 130 1.5× 157 1.8× 934 11.3× 28 1.4k
Hongwei Chen China 11 110 0.4× 90 0.7× 164 1.8× 233 2.7× 135 1.6× 36 721

Countries citing papers authored by Do H. Kim

Since Specialization
Citations

This map shows the geographic impact of Do H. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Do H. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Do H. Kim more than expected).

Fields of papers citing papers by Do H. Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Do H. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Do H. Kim. The network helps show where Do H. Kim may publish in the future.

Co-authorship network of co-authors of Do H. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Do H. Kim. A scholar is included among the top collaborators of Do H. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Do H. Kim. Do H. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Do H., L. Jeffrey Medeiros, Jie Xu, et al.. (2025). Diffuse Large B-Cell Lymphoma/High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Study of 60 Cases. Modern Pathology. 38(5). 100710–100710. 2 indexed citations
2.
Kim, Do H., Preetesh Jain, Michael Wang, et al.. (2024). TP53 mutation is frequent in mantle cell lymphoma with EZH2 expression and have dismal outcome when both are present. Human Pathology. 146. 1–7.
3.
Kim, Do H., Keyur P. Patel, Prithviraj Bose, et al.. (2024). Utility of KIT Mutations in Myeloid Neoplasms Without Documented Systemic Mastocytosis to Detect Hidden Mast Cells in Bone Marrow. Clinical Lymphoma Myeloma & Leukemia. 24(11). e878–e882. 1 indexed citations
4.
Marques‐Piubelli, Mario L., Do H. Kim, L. Jeffrey Medeiros, et al.. (2023). CD30 expression is frequently decreased in relapsed classic Hodgkin lymphoma after anti‐CD30 CAR T‐cell therapy. Histopathology. 83(1). 143–148. 10 indexed citations
5.
Khanlari, Mahsa, Huan Mo, Do H. Kim, et al.. (2023). Blastoid and Pleomorphic Mantle Cell Lymphoma Demonstrate Distinct Clinicopathologic and Genetic Features. The American Journal of Surgical Pathology. 47(8). 849–858. 4 indexed citations
6.
Kim, Do H. & Francisco Vega. (2022). Relapsed classic Hodgkin lymphoma with decreased CD30 expression after brentuximab and anti-CD30 CAR-T therapies. Blood. 139(6). 951–951. 9 indexed citations
7.
Fang, Hong, Sa A. Wang, Joseph D. Khoury, et al.. (2022). Pure erythroid leukemia is characterized by biallelic <i>TP53</i> inactivation and abnormal p53 expression patterns in <i>de novo</i> and secondary cases. Haematologica. 107(9). 2232–2237. 18 indexed citations
8.
Kim, Do H. & Xiaoping Sun. (2022). ALK-positive anaplastic large cell lymphoma that presented as pleural effusion. Blood Research. 57(1). 5–5.
9.
Zhang, Qingling, Do H. Kim, Yangwei Xu, Wei Wang, & L. Jeffrey Medeiros. (2021). Clinicopathological features of syncytial variant nodular sclerosis Hodgkin lymphoma. Human Pathology. 119. 105–113. 5 indexed citations
10.
Sakhdari, Ali, Huan Mo, Do H. Kim, et al.. (2021). EZH2 expression is associated with inferior overall survival in mantle cell lymphoma. Modern Pathology. 34(12). 2183–2191. 8 indexed citations
11.
Kim, Do H., Rashmi Kanagal‐Shamanna, Francisco Vega, et al.. (2021). Mantle cell lymphoma involving tonsils: a clinicopathologic study of 83 cases. Human Pathology. 118. 60–68. 2 indexed citations
12.
Cross, Robert W., Zachary A. Bornholdt, Abhishek N. Prasad, et al.. (2021). Combination therapy protects macaques against advanced Marburg virus disease. Nature Communications. 12(1). 1891–1891. 56 indexed citations
13.
Lee, Eun-Sung, Joung Eun Yoo, YongJoo Kim, et al.. (2020). Quasicrystalline phase-change memory. Scientific Reports. 10(1). 13673–13673. 3 indexed citations
14.
Wang, Kevin Yuqi, et al.. (2019). High-grade Features of Papillary Cystadenocarcinoma of the Parotid Gland. Oman Medical Journal. 34(2). 164–168. 1 indexed citations
15.
Pauly, Michael, Do H. Kim, Ognian Bohorov, et al.. (2015). Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide. Journal of Immunological Methods. 422. 111–117. 8 indexed citations
16.
Sully, Erin K., Kevin J. Whaley, Natasha Bohorova, et al.. (2014). Chimeric Plantibody Passively Protects Mice against Aerosolized Ricin Challenge. Clinical and Vaccine Immunology. 21(5). 777–782. 37 indexed citations
17.
Kim, Do H., et al.. (2012). Cone snail milked venom dynamics – A quantitative study of Conus purpurascens. Toxicon. 60(1). 83–94. 19 indexed citations
18.
19.
20.
Park, Mi‐Suk, et al.. (2011). Acinar cell carcinoma with fatty change arising from the pancreas. British Journal of Radiology. 84(1008). e226–e228. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiara Giudice Breakdown of academic impact, for papers by Philip Hartjen Breakdown of academic impact, for papers by Eric Verbeken Breakdown of academic impact, for papers by Felipe Tapia Breakdown of academic impact, for papers by Tobias May Breakdown of academic impact, for papers by Guan Liu Breakdown of academic impact, for papers by Shaobing Li Breakdown of academic impact, for papers by Corey J. Bishop Breakdown of academic impact, for papers by Hongwei Chen
Rankless by CCL
2026